Department of Otorhinolaryngology and Head and Neck Surgery, University Hospital Center Sestre Milosrdnice, Zagreb, Croatia.
Department of Otorhinology and Head and Neck Surgery, School of Medicine, University of Zagreb, Croatia.
Ear Hear. 2023;44(4):894-899. doi: 10.1097/AUD.0000000000001338. Epub 2023 Jan 20.
Systemic steroids are the most common first-line therapy in sudden sensorineural hearing loss (SSNHL), with significant improvement in hearing outcomes in over 60% of patients. It is unknown why 40% of patients do not respond to systemic steroid therapy. Salvage treatment includes intratympanic steroids (ITS) and hyperbaric oxygenation (HBO) therapy, with inconsistent results reported. This study aimed to compare the results of ITS and HBO therapy in patients with SSNHL that previously failed systemic steroid therapy.
This is a comparative retrospective nonrandomized interventional cohort study, enrolling 126 patients with SSNHL. Out of these, 35 patients received HBO therapy, 43 patients received ITS, and 48 patients did not receive any second-line therapy (control group). Pure-tone audiograms were performed before and after the salvage therapy in the IT and HBO groups and at the same time interval in the control group. Study variables included age, time until therapy initiation, tinnitus status, and hearing outcomes, with a cutoff criteria of cumulative >30 dB improvement on all frequencies indicating recovery.
ITS and HBO therapy were associated with statistically significant hearing recovery at all frequencies compared to systemic steroids. The results show an average hearing improvement of 13.6 dB overall frequencies (250 to 8000 Hz) after ITS therapy and 7.4 dB in HBO therapy in comparison to the control group. Presence of significant hearing improvement positively correlated with age, ITS therapy, and HBO therapy. Presence of tinnitus before therapy was negatively correlated with hearing improvement. Patients with tinnitus present at the start of therapy improve 4.67 dB less on average compared to those without tinnitus. ITS therapy significantly reduced tinnitus compared to the other two treatment options. Patients with tinnitus present before therapy significantly improve hearing at low frequencies, compared to the control group.
ITS and HBO therapy show superior hearing results compared to observation alone after failed oral steroid therapy for SSNHL. ITS shows an additional positive impact on tinnitus reduction and shows superior hearing outcomes after salvage therapy.
全身性类固醇是突发性聋(SSNHL)最常用的一线治疗方法,超过 60%的患者听力改善明显。但仍有 40%的患者对全身性类固醇治疗无反应,其原因尚不清楚。挽救性治疗包括鼓室内类固醇(ITS)和高压氧(HBO)治疗,但结果不一致。本研究旨在比较先前全身性类固醇治疗失败的 SSNHL 患者接受 ITS 和 HBO 治疗的结果。
这是一项比较性回顾性非随机干预性队列研究,共纳入 126 例 SSNHL 患者。其中 35 例患者接受 HBO 治疗,43 例患者接受 ITS 治疗,48 例患者未接受任何二线治疗(对照组)。ITS 和 HBO 组在挽救性治疗前后以及对照组在相同时间间隔进行纯音听力图检查。研究变量包括年龄、开始治疗的时间、耳鸣状态和听力结果,以所有频率累积改善>30dB 作为恢复的标准。
与全身性类固醇相比,ITS 和 HBO 治疗在所有频率上均与统计学上显著的听力恢复相关。结果显示,ITS 治疗后所有频率的平均听力改善为 13.6dB(250-8000Hz),HBO 治疗为 7.4dB,与对照组相比。有显著听力改善的患者与年龄、ITS 治疗和 HBO 治疗呈正相关。治疗前存在耳鸣与听力改善呈负相关。与无耳鸣患者相比,治疗开始时存在耳鸣的患者平均听力改善减少 4.67dB。与其他两种治疗选择相比,ITS 治疗显著降低了耳鸣。治疗前有耳鸣的患者与对照组相比,低频听力显著改善。
与单独观察相比,SSNHL 全身性类固醇治疗失败后,ITS 和 HBO 治疗在听力方面的效果更好。ITS 治疗除了对耳鸣减轻有额外的积极影响外,在挽救性治疗后也有更好的听力结果。